KSKamran Samakar

Kamran Samakar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kamran Samakar has a total of 97 co-authors. Here are the top co-authors by number of shared publications:

  • Jamil S. Samaan

    Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA

    10 shared publications
  • Jamil S. Samaan

    Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, USA

    8 shared publications
  • Agnes Premkumar

    Department of General Surgery, Creighton University of Phoenix, Phoenix, USA

    3 shared publications
  • Alaina P. Vidmar

    Center for Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Children’s Hospital Los Angeles and Keck School of Medicine of University of Southern California, Los Angeles, CA, USA

    3 shared publications
  • Elaine Qian

    Division of Upper GI & General Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, USA

    3 shared publications
  • Evan T. Alicuben

    Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA

    3 shared publications

Latest Publications

  • Open Access

    Toward an intergenerational model of metabolic and bariatric surgery: reframing the household as the unit of care

    by Alaina P. Vidmar, Kamran Samakar, Matthew J. Martin, John Magaña Morton

    Obesity is a chronic, relapsing disease that increasingly spans generations within households, yet contemporary metabolic and bariatric surgery (MBS) models remain oriented toward individuals or single-generation patients. A growing body of evidence demonstrates that obesity risk, behaviors, and treatment responses cluster within family systems, and that MBS produces measurable metabolic and behavioral effects among untreated spouses, partners, and children. Concurrently, decades of pediatric research confirm that caregiver engagement and integration is one of the strongest determinants of successful obesity treatment. Together, these observations support a paradigm shift toward an intergenerational, family-centered model of MBS, in which the household becomes the unit of care. This perspective synthesizes evidence supporting the biological, behavioral, and environmental interdependence of obesity within families and outlines a comprehensive framework for implementing household-level bariatric care. Core components include integrated pediatric–adult clinical infrastructure; combined multidisciplinary teams trained across the age spectrum; harmonized protocols for evaluation, education, and follow-up; coordinated scheduling and workflow alignment; and family-based behavioral strategies that promote shared goals, consistent routines, and mutual accountability. Operational and policy innovations, such as cross-departmental agreements, unified electronic health records, and coordinated billing can facilitate sustainable implementation. We further identify research priorities, including quantifying metabolic ripple effects among untreated family members, evaluating bundled household-level interventions, and developing validated metrics to assess changes in the home environment. Treating the household as the patient offers a promising strategy to enhance medical obesity treatment, surgical durability, improve adherence, and disrupt intergenerational transmission of obesity. As obesity increasingly presents as a family condition, an intergenerational MBS model may help realign treatment with the realities of lived experience and improve outcomes across generations.

  • Open Access

    Short-Term Safety and Healthcare Utilization Following Intragastric Balloon Placement in Patients With and Without Diabetes Mellitus: A Propensity-Matched Analysis

    by Sevag Hamamah, Jamil S. Samaan, Nadine Soliman, Stephanie Nguyen, Rashmi Advani, Kamran Samakar, Kulmeet K. Sandhu, Kenneth Park, Barham K. Abu Dayyeh, Rabindra R. Watson

    Background: Intragastric balloon (IGB) therapy is a minimally invasive endoscopic intervention for weight reduction in patients with Class I-II obesity and in lower BMI patients with obesity-related comorbidities such as diabetes mellitus. Diabetes mellitus is associated with vascular complications, increased susceptibility to infection and delayed gastric emptying, underscoring the need to evaluate procedural safety and device tolerance in this population. However, evidence regarding short-term safety in this higher-risk population remains limited. This study aims to compare 30-day safety outcomes after IGB placement in patients with and without diabetes mellitus. Methods: This was a retrospective cohort study of 4,555 patients undergoing primary IGB placement using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database from 2015 to 2023. Propensity score-matching was performed in R version 4.5.0 to balance baseline characteristics in two matched analyses: (1) patients with diabetes mellitus matched to patients without diabetes mellitus, and (2) non-insulin dependent diabetes mellitus (NIDDM) versus insulin-dependent diabetes mellitus (IDDM). Outcomes included 30-day rates of outpatient intravenous (IV) treatments, emergency department (ED) visits, hospital readmissions, reoperations, procedural interventions, and serious adverse events (SAEs). Results: Patients with diabetes, particularly those with insulin dependence, were older, more frequently male, and had a higher burden of cardiometabolic-associated medical problems compared to patients without diabetes. Among 424 propensity-matched patients with and without diabetes, rates of 30-day healthcare utilization including outpatient IV treatment, ED visit, hospital readmission, reoperation, and procedural intervention were comparable. Postoperative SAEs were rare, with no observed significant differences in rates of organ space infection, pneumonia, unplanned intubation, pulmonary embolism, deep vein thrombosis, prolonged mechanical ventilation, urinary tract infection, renal insufficiency, acute renal failure, cerebrovascular accident, cardiac arrest, myocardial infarction, sepsis, septic shock, unplanned intensive care unit admission and mortality. In a sub-analysis of 106 matched patients with NIDDM and IDDM, 30-day healthcare utilization and all postoperative SAEs were likewise similar, with no observed statistically significant differences between cohorts. Conclusion: Patients with diabetes exhibited a greater burden of associated medical problems but demonstrated comparable rates of short-term healthcare utilization, safety outcomes and tolerability to those without diabetes after adjustment for baseline differences. These findings support the safety of IGB placement in patients with diabetes and suggest it may be considered both as a safe option for primary weight loss intervention or as a bridge therapy to Metabolic and Bariatric Surgery (MBS) in this population.

  • Open Access

    Safety Profile of Primary Intragastric Balloon Placement in Class III Obesity: An MBSAQIP Analysis of 4,555 Patients

    by Sevag Hamamah, Jamil S. Samaan, Nadine Soliman, Stephanie Nguyen, Nitin Srinivasan, Faizi Hai, Kamran Samakar, Kulmeet K. Sandhu, Kenneth Park, Barham K. Abu Dayyeh, et al.

    Background: Intragastric balloon (IGB) therapy is a minimally invasive endoscopic intervention primarily utilized for weight reduction in patients with Class I and II obesity. While less frequently utilized in individuals with Class III obesity (BMI ≥ 40 kg/m²), IGB placement may be considered as a bridge to bariatric surgery or when surgery is contraindicated or declined. However, data regarding short-term safety outcomes in this higher-risk population remain limited. Objective: This study aims to compare 30-day safety outcomes after IGB placement in patients with BMI ≥ 40 kg/m² versus BMI < 40 kg/m². Methods: This was a retrospective cohort study of 4,555 patients undergoing primary IGB placement from 2016 to 2023 using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database. Primary outcomes included hospital length of stay and 30-day rates of outpatient intravenous (IV) treatments, emergency department (ED) visits, readmissions, reoperations, interventions, and mortality. Patients were stratified by BMI ≥ 40 kg/m² and BMI < 40 kg/m² for comparative analysis using propensity score-matching (PSM). 962 pairs were identified for PSM. Results: Patients with BMI ≥ 40 kg/m² were younger on average and more likely to be male and non-Hispanic Black. This group exhibited a higher prevalence of associated medical problems, including diabetes, obstructive sleep apnea, hypertension, renal insufficiency, immunosuppressant use, thromboembolic events, and therapeutic anticoagulation use. After adjustment for baseline differences, patients with BMI ≥ 40 kg/m² were more likely to require a postoperative hospital length of stay longer than one day ( p = 0.003). No significant differences in 30-day outpatient IV treatments, ED visits, readmissions, reoperations, interventions, or mortality, were observed. Conclusion: Patients with BMI ≥ 40 kg/m² exhibited a greater burden of associated medical problems and longer hospital length of stay, but otherwise demonstrated comparable short-term safety outcomes to those with BMI < 40 kg/m². These findings suggest comparable 30-day hospital-based safety outcomes after IGB placement in patients with BMI ≥ 40 kg/m² compared with BMI < 40 kg/m².


  • Open Access

    Perspectives of Patients Seeking Bariatric Surgery: The Impact of Early Patient-Provider Communication on Bariatric Surgery Utilization

    by Nitin Srinivasan, Jamil Samaan, Nithya Rajeev, Agnes Premkumar, Kelvin Alvarez, Lucy Harvey, Stephanie Nguyen, Ashley Tran, Kamran Samakar

    Introduction: Bariatric surgery (BS) is an effective and durable long-term treatment for severe obesity, yet less than 1% of eligible patients undergo surgery. Thus, we explored the perceptions and experiences of patients with obesity seeking BS prior to obtaining a referral for surgery. Methods: A survey was prospectively administered to patients who were referred to our institution from March 25, 2023, to May 28, 2024. Questions assessed patients' initial exposure to BS, perceptions of its safety and efficacy, who initiated referral discussions, and whether patients would have considered surgery earlier if prompted by their healthcare provider. Statistical analyses included Chi-square test. Qualitative analysis using thematic analysis was conducted for free-text responses. Results: Out of 327 patients invited, 118 completed the survey (36.1%). The majority of participants (57.9%) initiated discussions about BS with their provider, and 79.7% would have considered BS sooner if approached earlier. Respondents had considered BS for 3.8 years on average (standard deviation = 5.3). The most important contributions of BS for patients were “improved health” (94.1%) and “improved appearance” (31.6%). The most commonly reported barriers to obtaining a referral included cost (55.1%), followed by safety (45.8%) and efficacy (33.1%) concerns. Discussion: Our findings underscore the importance of proactive and early engagement between providers and patients regarding BS referrals. Addressing safety and efficacy concerns through comprehensive patient education by providers may improve BS referral rates by removing patients’ perceived barriers to care. Financial concerns remain a significant barrier to BS utilization and should be further investigated and addressed.


  • Open Access

    Type 2 Diabetes in a 4-Year-Old With Obesity: Considerations for Use of Semaglutide and Bariatric Surgery in Children

    by James Connard, Armine Simonian, Roshanak Monzavi, Kamran Samakar, Alaina P Vidmar

    The rising prevalence of youth-onset type 2 diabetes (T2D) in children necessitates early intervention with tight glycemic control, obesity medications, and metabolic and bariatric surgery (MBS). Insulin and metformin are standard treatments, but additional therapies for obesity in youth are needed. A 4-year-old Hispanic female with early-onset obesity and newly diagnosed T2D presented with a hemoglobin A1c (HbA1c) level of 8.0% (reference: < 5.7%), a fasting glucose of 147 mg/dL (SI units: 8.17 mmol/L) (reference: 70-115 mg/dL [3.33-6.39 mmol/L]), and a body mass index (BMI) of 41 kg/m². She had rapid weight gain and hyperphagia. Initially, insulin therapy was started, and her HbA1c decreased to 6.7% over 6 months. Insulin was discontinued and metformin 1000 mg twice daily was started. Topiramate 75 mg nightly was prescribed for obesity with minimal effect and so semaglutide was started and titrated to 2 mg weekly. By 27 months, her HbA1c improved to 5.1%, and overall, she had a 12% reduction in her percent above the 95th percentile (%BMIp95; BMI 41 kg/m²→35 kg/m²; %BMIp95 = 205%→190%). This case underscores the importance of a multi-modal approach to managing pediatric T2D and obesity and highlights the effectiveness of semaglutide in improving both obesity and glycemic control.


  • Open Access

    Early Reinitiation of Obesity Pharmacotherapy Post Laparoscopic Sleeve Gastrectomy in Youth: A Retrospective Cohort Study

    by Alaina P. Vidmar, My H. Vu, Matthew J. Martin, Aimee G. Kim, Stuart Abel, Madeleine Weitzner, Cynthia E. Muñoz, Ahlee Kim, Kamran Samakar

    Background: Bariatric surgery is the most effective intervention for severe pediatric obesity, but a subset of youth experience suboptimal weight loss and/or recurrent weight gain. Early re-initiation of obesity pharmacotherapy postoperatively may improve outcomes, though this has not been evaluated in pediatric populations. Methods: A retrospective cohort study at a tertiary care children’s hospital evaluated the safety and efficacy of reintroducing obesity pharmacotherapy within six weeks after laparoscopic sleeve gastrectomy (LSG). Youth were offered obesity pharmacotherapy reinitiation at their 2-week postoperative visit. The study compared outcomes between 25 youth who chose early obesity pharmacotherapy reinitiation and 21 who received standard care without restarting medication. Primary outcomes included weight trajectory, eating behaviors, complications, readmissions, and reoperation rates, analyzed using independent t-tests, Chi-squared tests, and logistic regressions. Results: Between November 2023 and July 2024, 53 youth had surgical consults, and 46 (86% conversion rate; mean age 16.5 ± 1.9 years, mean BMI 53 ± 9.7 kg/m2; 70% (32/46) female, 80% (37/46) Hispanic, 87% (40/46) publicly insured) underwent LSG, with 93% (43/46) using obesity pharmacotherapy preoperatively. Mixed-effects multivariate regression, adjusting for baseline BMI, age, and sex, revealed that early reinitiation (5.1 weeks [IQR 3.7, 8.4]) significantly reduced BMI, percent BMI, percent total weight loss (TWL), and percent excess weight loss (EWL) at 3 and 6 months compared to standard care, with no significant differences in complications or readmissions. At 6 months, the mean differences were: %BMI: -6.5% (95% CI: -9.13, -3.86), p < 0.001; %TWL: -5.9% (95% CI: -8.52, -3.25), p < 0.001; %EWL: Reinitiators: -45.5% vs. standard care: -39.4%; mean difference: -8.2% (95% CI: -14.69, -1.63), p < 0.001. Early reinitiation also resulted in a significant reduction in emotional overeating at 3 and 6 months compared to standard care, with mean differences of -2.5 points (95% CI: -3.29, -1.76), p < 0.001, and -3.5 points (95% CI: -4.38, -2.69), p < 0.001, respectively on self-reported eating behavior questionnaires. Conclusion: Early obesity pharmacotherapy reinitiation after LSG was safe and well tolerated, improving weight outcomes without negatively impacting complication or readmission rates.


  • Top Cited Papers
    Open Access

    Large language models and bariatric surgery patient education: a comparative readability analysis of GPT-3.5, GPT-4, Bard, and online institutional resources

    by Nitin Srinivasan, Jamil S. Samaan, Nithya D. Rajeev, Mmerobasi U. Kanu, Yee Hui Yeo, Kamran Samakar

    Background: The readability of online bariatric surgery patient education materials (PEMs) often surpasses the recommended 6th grade level. Large language models (LLMs), like ChatGPT and Bard, have the potential to revolutionize PEM delivery. We aimed to evaluate the readability of PEMs produced by U.S. medical institutions compared to LLMs, as well as the ability of LLMs to simplify their responses. Methods: Responses to frequently asked questions (FAQs) related to bariatric surgery were gathered from top-ranked health institutions. FAQ responses were also generated from GPT-3.5, GPT-4, and Bard. LLMs were then prompted to improve the readability of their initial responses. The readability of institutional responses, initial LLM responses, and simplified LLM responses were graded using validated readability formulas. Accuracy and comprehensiveness of initial and simplified LLM responses were also compared. Results: Responses to 66 FAQs were included. All institutional and initial LLM responses had poor readability, with average reading levels ranging from 9th grade to college graduate. Simplified responses from LLMs had significantly improved readability, with reading levels ranging from 6th grade to college freshman. When comparing simplified LLM responses, GPT-4 responses demonstrated the highest readability, with reading levels ranging from 6th to 9th grade. Accuracy was similar between initial and simplified responses from all LLMs. Comprehensiveness was similar between initial and simplified responses from GPT-3.5 and GPT-4. However, 34.8% of Bard's simplified responses were graded as less comprehensive compared to initial. Conclusion: Our study highlights the efficacy of LLMs in enhancing the readability of bariatric surgery PEMs. GPT-4 outperformed other models, generating simplified PEMs from 6th to 9th grade reading levels. Unlike GPT-3.5 and GPT-4, Bard’s simplified responses were graded as less comprehensive. We advocate for future studies examining the potential role of LLMs as dynamic and personalized sources of PEMs for diverse patient populations of all literacy levels.


  • Trends in the mortality of intra-abdominal infections in adults over 25 years in the USA, 1999–2021

    by Yi Liu, Jamil S Samaan, Youssef M Essanaa, Fan Lv, Fanpu Ji, Kamran Samakar, Yee Hui Yeo

  • Open Access

    Providers’ Knowledge and Perceptions of Bariatric Surgery: a Systematic Review

    by Nithya D. Rajeev, Jamil S. Samaan, Agnes Premkumar, Erin Yu, Nitin Srinivasan, Kamran Samakar

    Bariatric surgery remains underutilized despite its proven efficacy in the management of obesity. Provider perceptions of bariatric surgery are important to consider when discussing utilization rates. PubMed, SCOPUS, and OVID databases were searched in April 2023, and 40 published studies discussing providers’ knowledge and perceptions of bariatric surgery were included. There were generally positive perceptions of the efficacy of bariatric surgery, although overestimations of surgical risks and postoperative complications were common. Providers’ previous training was associated with knowledge and perceptions of bariatric surgery and familiarity with perioperative management across studies. These perceptions were also associated with referral rates, suggesting that inadequate provider knowledge may contribute to bariatric surgery underutilization. We advocate for increased bariatric surgery-related education throughout all stages of medical training and across specialties.


  • Sa1115 MORTALITY TRENDS IN THE UNITED STATES FOR NON-COVID-19 RELATED INTRA-ABDOMINAL INFECTIONS BEFORE AND DURING THE PANDEMIC

    by Jamil S. Samaan, Yi Liu, Youssef Essanaa, Barbara Hollander, Fan Lv, Fanpu Ji, Kamran Samakar, Yee Hui Yeo